Market
Zenflow raises $52m for BPH implant and inks US distribution pact with Cook Medical
Zenflow raised $52 million in funding and signed a US distribution agreement with Cook Medical for its Spring implant, a device cleared by the FDA in December 2025 to treat benign prostatic hyperplasia symptoms. The funding and partnership expand commercial availability of the urology-focused implant in the US market.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network